- Home
- KTTA vs CRNX Comparison
KTTA vs CRNX Comparison
Compare KTTA & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KTTA
- CRNX
- Stock Information
- Founded
- KTTA 2020
- CRNX 2008
- Country
- KTTA United States
- CRNX United States
- Employees
- KTTA N/A
- CRNX N/A
- Industry
- KTTA Biotechnology: Pharmaceutical Preparations
- CRNX Biotechnology: Pharmaceutical Preparations
- Sector
- KTTA Health Care
- CRNX Health Care
- Exchange
- KTTA Nasdaq
- CRNX Nasdaq
- Market Cap
- KTTA 2.8M
- CRNX 2.8B
- IPO Year
- KTTA 2021
- CRNX 2018
- Fundamental
- Price
- KTTA $0.75
- CRNX $29.44
- Analyst Decision
- KTTA
- CRNX Strong Buy
- Analyst Count
- KTTA 0
- CRNX 10
- Target Price
- KTTA N/A
- CRNX $75.00
- AVG Volume (30 Days)
- KTTA 168.4K
- CRNX 641.8K
- Earning Date
- KTTA 08-12-2025
- CRNX 08-07-2025
- Dividend Yield
- KTTA N/A
- CRNX N/A
- EPS Growth
- KTTA N/A
- CRNX N/A
- EPS
- KTTA N/A
- CRNX N/A
- Revenue
- KTTA N/A
- CRNX $760,000.00
- Revenue This Year
- KTTA N/A
- CRNX $402.12
- Revenue Next Year
- KTTA N/A
- CRNX $770.88
- P/E Ratio
- KTTA N/A
- CRNX N/A
- Revenue Growth
- KTTA N/A
- CRNX N/A
- 52 Week Low
- KTTA $0.70
- CRNX $24.10
- 52 Week High
- KTTA $7.50
- CRNX $62.53
- Technical
- Relative Strength Index (RSI)
- KTTA 38.00
- CRNX 42.12
- Support Level
- KTTA $0.70
- CRNX $28.34
- Resistance Level
- KTTA $0.76
- CRNX $30.85
- Average True Range (ATR)
- KTTA 0.04
- CRNX 1.10
- MACD
- KTTA 0.01
- CRNX -0.24
- Stochastic Oscillator
- KTTA 27.26
- CRNX 25.52
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.